Brief: Eiger Biopharmaceuticals, Inc. Announces 1-For-30 Reverse Stock Split
04/01/2024 13:54
Jan 4 (Reuters) - Eiger BioPharmaceuticals Inc EIGR.O :
* EIGER BIOPHARMACEUTICALS, INC. ANNOUNCES 1-FOR-30 REVERSE
STOCK
SPLIT
* REVERSE STOCK SPLIT WILL BECOME EFFECTIVE AT 11:59 P.M.
EASTERN
TIME, ON JANUARY 5, 2024.
* COMPANY'S COMMON STOCK WILL BEGIN TRADING ON A POST-SPLIT
BASIS
AT MARKET OPEN ON JANUARY 8, 2024
* REVERSE STOCK SPLIT,CO'S PLAN TO REGAIN COMPLIANCE WITH
MINIMUM
BID PRICE REQUIREMENT TO MAINTAIN CONTINUED LISTING ON NASDAQ
Source text for Eikon: ID:nPn9qWhRxa
Further company coverage: EIGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview